Most of the above mentioned NK cell activating ligands, including NKG2DLs and B7-H6, are absent in normal cells but their expression is induced upon neoplastic transformation, thus rendering tumor cells more susceptible to NK cell-mediated killing (29, 36–41). The gene discussed is NCR3LG1; the disease is neoplasm.